NCT04752826 2026-02-18
MK-3475-D20
BioInvent International AB
Phase 1/2 Recruiting
BioInvent International AB
BioInvent International AB
Taiho Oncology, Inc.
Evopoint Biosciences Inc.
Bayer
Bayer
AstraZeneca
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc.
Sandoz
PharmaMar
DUSA Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC